肿瘤药敏指导下的化疗对非小细胞肺癌并恶性胸水治疗的有效性(英文)

查看全文 作　　者：Kaijian [1]Le;Yuming [1]Jia;Jing [1]Wang;Maoqiong [1]Jiang

机构地区：[1]Department of Oncology,The No. 2 People's Hospital of Yibin

出　　处：《The Chinese-German Journal of Clinical Oncology》索引2013年第12卷第5期,共3页

摘　　要：Objective:The aim of the study was to investigate the clinical value and application of ATP based bioluminescence tumor chemosensitivity assay (ATP-TCA) in the chemotherapy for hydrothorax caused by non-small cell lung cancer (NSCLC). Methods:Hydrothorax specimens from 120 NSCLC patients were analyzed by ATP-TCA and the most sensitive chemotherapeutic drugs were used in NSCLC patients (treatment group). At the same time, 56 NSCLC patients with hydrothorax were admitted in our Hospital (Department of Oncology, The No. 2 People's Hospital of Yibin, China) and given chemotherapy without guidance of the ATP-TCA (control group). Before the third chemotherapeutic cycle, clinical outcomes were analyzed in the two groups. Results:Effective rate of hydrothorax in treatment group was 67%, while 46% in control group (P < 0.05). In refractory hydrothorax patients, they were 69% and 40% (P < 0.05), respectively. In vitro results correlated well with clinical outcomes (P < 0.01). Conclusion:Effective rate of chemotherapy for hydrothorax in NSCLC is higher in treatment group than that in control group. ATP-TCA is especially helpful for refractory hydrothorax. 关键词：非小细胞肺癌化疗药物临床应用药敏试验 ATP 胸水肿瘤价值

相关文献

参考文献（5）
引证文献（1）
耦合文献（5）

参考文献(5)

引证文献(1)

耦合文献(5)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

肿瘤药敏指导下的化疗对非小细胞肺癌并恶性胸水治疗的有效性(英文)

参考文献(5)

引证文献(1)

耦合文献(5)

用户提示